Dongcheng Pharmaceutical: Legal Opinion of Beijing Zhonglun Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Yantai Dongcheng Pharmaceutical Group Co., Ltd.

Dec 30, 2024 11:00 ET

Dongcheng Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders

Dec 30, 2024 11:00 ET

Dongcheng Pharmaceutical: Announcement on subsidiary companies providing guarantees to their wholly-owned subsidiaries

Dec 13, 2024 11:00 ET

Dongcheng Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024

Dec 12, 2024 11:00 ET

Dongcheng Pharmaceutical: Announcement on wholly-owned subsidiaries receiving government subsidies

Dec 10, 2024 11:00 ET

Dongcheng Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders

Nov 18, 2024 11:00 ET

Dongcheng Pharmaceutical: Legal Opinion of Beijing Zhonglun Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Yantai Dongcheng Pharmaceutical Group Co., Ltd.

Nov 18, 2024 11:00 ET

Dongcheng Pharmaceutical: Announcement on wholly-owned subsidiaries receiving government subsidies

Nov 5, 2024 11:00 ET

Dongcheng Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024

Oct 28, 2024 12:00 ET

Dongcheng Pharmaceutical: Announcement on the holding subsidiary obtaining a notice of approval for drug clinical trials

Sep 20, 2024 12:00 ET

Dongcheng Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary

Aug 30, 2024 12:00 ET

Dongcheng Pharmaceutical: 2024 Semi-Annual Financial Report

Aug 30, 2024 12:00 ET

Yantai Dongcheng Biochemicals: Announcement Regarding the Holding Subsidiary Receiving Drug Clinical Trial Approval Notification

Aug 2, 2024 12:00 ET

Yantai Dongcheng Biochemicals: Announcement on the Obtaining of State Food and Drug Administration Approval for Technetium (99mTc) Tetrofosmin Injection

Jul 5, 2024 12:00 ET

Yantai Dongcheng Biochemicals: Announcement Regarding the Launch of Operations at Hefei Nuclear Medicine Production Center.

Jun 13, 2024 12:00 ET

Yantai Dongcheng Biochemicals: Announcement on the holding subsidiary obtaining a notice of approval for drug clinical trials

May 24, 2024 12:00 ET

Yantai Dongcheng Biochemicals: Legal Opinion of Beijing Zhonglun Law Firm on the 2023 Annual General Meeting of Shareholders of Yantai Dongcheng Pharmaceutical Group Co., Ltd.

May 17, 2024 12:00 ET

Yantai Dongcheng Biochemicals: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 17, 2024 12:00 ET

Yantai Dongcheng Biochemicals: Announcement on the subsidiary company being recognized as a specialized, special and new small and medium-sized enterprise in Hebei Province

May 15, 2024 12:00 ET

Yantai Dongcheng Biochemicals: Announcement on the holding subsidiary obtaining a notice of approval for drug clinical trials

Apr 28, 2024 20:00 ET